Control of Tata Sons is at risk after the holding company's board reappointed N Chandrasekaran and endorsed a plan to list the group, steps opposed by its largest shareholder, Tata Trusts. The trust, which holds 66% of Tata Sons, labelled the board decision illegal and said it will explore options other than a listing, setting up a likely legal and governance confrontation.
The reappointment was approved by the Nomination and Remuneration Committee but has already been challenged as beyond that committee's authority. Nitin Potdar, a Mumbai corporate lawyer, said the NRC "can only make a recommendation" and argued the action also conflicts with the firm's governance code that expects executives to step down at 65. Chandrasekaran received a five-year extension and will reach 65 in 2028, leaving his future vulnerable if the resolution fails at the company's next annual meeting.
The AGM must be held before 31 December after a prior meeting was adjourned for lack of quorum, but no new date has been announced. Tata Trusts is expected to vote against the reappointment, which could overturn the board's move and prolong uncertainty over leadership at Bombay House, the group's Mumbai headquarters.
Beyond the personnel dispute, regulators have pushed the group toward a public listing. In 2022 the Reserve Bank of India classified Tata Sons as an upper layer non-banking financial company because of its size and investment role, a designation that triggered a listing obligation. The RBI this month rejected Tata Sons' petition to exit that framework, and has already approached courts to be heard first in any listing-related litigation.
The market reacted sharply to the turmoil, with Tata Group stocks initially rising then falling as investors weighed the risks. Critics warn a public Tata Sons would dilute the special control enjoyed by Tata Trusts and could shift dividend policy away from funding hospitals, universities and research. Potdar warned, "A new group of shareholders might say, 'Don't declare dividends; we need to reinvest this money in the companies.' What happens then? The first casualty will be the hospitals they run." Others argue listing would impose tougher scrutiny and more accountability for capital allocation across the group's sprawling businesses.
Legal challenges now appear likely, and the coming weeks will determine whether the board's decision survives an AGM and any court review. The row exposes tensions between the group's tradition of charity-led control and growing regulatory and market pressure to make Tata Sons answerable to outside investors.
